Aureus Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-8,423
| Closed | -$237K | – | 252 |
|
|
2026
Q1 | $237K | Buy |
+8,423
| New | +$224K | 0.02% | 204 |
|
|
2025
Q2 | – | Sell |
-9,534
| Closed | -$242K | – | 217 |
|
|
2025
Q1 | $242K | Buy |
9,534
+459
| +5% | +$12K | 0.02% | 180 |
|
|
2024
Q4 | $241K | Buy |
+9,075
| New | +$246K | 0.02% | 184 |
|
|
2024
Q2 | – | Sell |
-7,925
| Closed | -$220K | – | 210 |
|
|
2024
Q1 | $220K | Sell |
7,925
-2,032
| -20% | -$56.4K | 0.02% | 178 |
|
|
2023
Q4 | $287K | Sell |
9,957
-1,647
| -14% | -$49.8K | 0.02% | 154 |
|
|
2023
Q3 | $385K | Buy |
11,604
+1,010
| +10% | +$35.7K | 0.03% | 136 |
|
|
2023
Q2 | $389K | Sell |
10,594
-660
| -6% | -$25.7K | 0.03% | 133 |
|
|
2023
Q1 | $459K | Sell |
11,254
-2,301
| -17% | -$99.4K | 0.04% | 121 |
|
|
2022
Q4 | $695K | Buy |
+13,555
| New | +$650K | 0.06% | 109 |
|
|
2022
Q1 | – | Sell |
-3,742
| Closed | -$221K | – | 231 |
|
|
2021
Q4 | $221K | Buy |
+3,742
| New | +$185K | 0.01% | 194 |
|
|
2021
Q3 | – | Sell |
-9,380
| Closed | -$367K | – | 229 |
|
|
2021
Q2 | $367K | Buy |
+9,380
| New | +$365K | 0.02% | 165 |
|
|
2019
Q1 | – | Sell |
-8,627
| Closed | -$357K | – | 177 |
|
|
2018
Q4 | $357K | Buy |
8,627
+12
| +0.1% | +$498 | 0.06% | 118 |
|
|
2018
Q3 | $360K | Buy |
8,615
+6
| +0.1% | +$231 | 0.05% | 136 |
|
|
2018
Q2 | $296K | Buy |
8,609
+2,385
| +38% | +$81.5K | 0.04% | 152 |
|
|
2018
Q1 | $210K | Sell |
6,224
-1,245
| -17% | -$42.8K | 0.03% | 167 |
|
|
2017
Q4 | $257K | Sell |
7,469
-627
| -8% | -$21.4K | 0.04% | 154 |
|
|
2017
Q3 | $274K | Sell |
8,096
-65
| -0.8% | -$2.09K | 0.04% | 151 |
|
|
2017
Q2 | $260K | Sell |
8,161
-5,897
| -42% | -$186K | 0.04% | 138 |
|
|
2017
Q1 | $441K | Sell |
14,058
-238
| -2% | -$7.5K | 0.08% | 104 |
|
|
2016
Q4 | $441K | Buy |
14,296
+864
| +6% | +$26.4K | 0.09% | 95 |
|
|
2016
Q3 | $432K | Buy |
13,432
+5,031
| +60% | +$168K | 0.09% | 94 |
|
|
2016
Q2 | $281K | Buy |
+8,401
| New | +$268K | 0.06% | 97 |
|
|
2016
Q1 | – | Sell |
-7,603
| Closed | -$233K | – | 137 |
|
|
2015
Q4 | $233K | Sell |
7,603
-2,219
| -23% | -$69.8K | 0.05% | 121 |
|
|
2015
Q3 | $293K | Sell |
9,822
-1,590
| -14% | -$51K | 0.07% | 114 |
|
|
2015
Q2 | $363K | Buy |
11,412
+2,984
| +35% | +$97.3K | 0.08% | 115 |
|
|
2015
Q1 | $278K | Buy |
+8,428
| New | +$268K | 0.06% | 120 |
|
|
2014
Q4 | – | Sell |
-7,683
| Closed | -$216K | – | 139 |
|
|
2014
Q3 | $216K | Buy |
7,683
+575
| +8% | +$16.1K | 0.05% | 117 |
|
|
2014
Q2 | $200K | Buy |
7,108
+263
| +4% | +$7.5K | 0.05% | 133 |
|
|
2014
Q1 | $209K | Buy |
+6,845
| New | +$204K | 0.05% | 148 |
|
Other funds holding PFE
Aureus Asset Management's PFE Position: Q2 2026 in Review
Aureus Asset Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,423 shares — an estimated $237K sold.
Aureus Asset Management first reported a position in PFE in Q1 2014 and held it in 29 quarters. The position peaked at $695K in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Aureus Asset Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Aureus Asset Management sold 8,423 Pfizer shares in Q2 2026, an estimated $237K.
- Aureus Asset Management first reported a position in Pfizer in Q1 2014 and held it in 29 quarters.
- Aureus Asset Management's Pfizer position peaked at $695K in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Aureus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.